Breast Pump denied as not FDA-approved for this use by Aetna?

Aetna's specific coverage criteria for breast pump are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Used "Not FDA-Approved" to Deny Your Breast Pump — and Why to Challenge It

A "not FDA-approved" denial for a breast pump is highly unusual and almost certainly reflects a classification or coding error. Breast pumps sold in the United States are regulated by the FDA as Class II medical devices and must comply with FDA requirements before reaching the market. A denial asserting that a commercially available breast pump is not FDA-approved should be challenged immediately as a factual error. Additionally, the ACA's preventive-services mandate requires non-grandfathered plans to cover breastfeeding equipment — including breast pumps — without cost-sharing under HRSA Women's Preventive Services Guidelines. An FDA-approval denial that effectively eliminates a federally mandated benefit is doubly challengeable.

## Your Federal Appeal Rights

• Internal appeal: Submit within the timeframe on your EOB. Aetna must respond within 30 days (pre-service) or 60 days (post-service).
• External review (ACA §2719): After a final internal denial, you have approximately four months to request independent external review by a neutral, accredited organization.
• ACA preventive-services mandate: Cite the HRSA Women's Preventive Services Guidelines directly. A device that is both FDA-regulated and mandated by federal law as a covered preventive service cannot be lawfully denied on FDA-approval grounds.
• Expedited review: Available if delay poses a clinical risk.

## What to Gather

1. FDA device classification — look up the specific breast pump model on the FDA's publicly available medical device database (510(k) clearance or equivalent) to confirm its regulatory status, and include this documentation in your appeal. 2. The denial letter — identify the exact policy provision Aetna invoked and the specific HCPCS or product code under review. 3. Supplier documentation — a letter from the DME supplier or manufacturer confirming the device's FDA regulatory status and the applicable code under which it was billed. 4. ACA preventive-services citation — reference HRSA Women's Preventive Services Guidelines and the ACA's cost-sharing prohibition as independent grounds for coverage. 5. Clinician's letter — if the pump was prescribed for a specific clinical condition, include documentation of medical necessity as an additional coverage basis.

## Criteria-Mapping Structure

Challenge the FDA-approval characterization directly: (1) provide the device's FDA regulatory documentation; (2) demonstrate that the policy's "not FDA-approved" provision does not apply to a device that holds the applicable FDA clearance; and (3) establish the ACA preventive-services mandate as an independent and controlling coverage basis.

## Bottom Line

This denial type is almost always a factual error. A brief, well-documented appeal providing the device's FDA clearance documentation and citing the ACA mandate resolves these denials efficiently. Do not let an incorrect classification stand unchallenged.